Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Carlsmed (CARL) Income from Continuing Operations (2024 - 2026)

Carlsmed filings provide 2 years of Income from Continuing Operations readings, the most recent being 8620000.0 for Q4 2025.

  • On a quarterly basis, Income from Continuing Operations fell 84.78% to 8620000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 28275000.0, a N/A change, with the full-year FY2025 number at 29306000.0, down 21.54% from a year prior.
  • Income from Continuing Operations hit 8620000.0 in Q4 2025 for Carlsmed, down from 8461000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 4665000.0 in Q4 2024 to a low of 8620000.0 in Q4 2025.